Skip to main content

MEDIFAST INC

For the period ended Jun 18, 2025. Filed Apr 29, 2025.

View on SEC.gov

About this filing

What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.

Jun 18, 2025 · Filed Apr 29, 2025

Use the contents to explore the available documents and sections.

MED$12.81+0.6%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits
Contents

Cover page

Show cover page

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a)ofthe

Securities Exchange Actof 1934

Filed by the Registrant ☒

Filed by a Party other than the Registrant ☐

Check the appropriate box:
☐Preliminary Proxy Statement
☐Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
☒Definitive Proxy Statement
☐Definitive Additional Materials
☐Soliciting Material Pursuant to 240.14a-12

MEDIFAST, INC.

(Name of Registrant as Specified In Its Charter)

(Name of Person(s) Filing Proxy Statement ifotherthan the Registrant)

Payment of Filing Fee (Check all boxes that apply):
☒No fee required
☐Fee paid previously with preliminary materials
☐Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11

Notice of Annual Meeting

and Proxy Statement

Annual Meeting of Stockholders

Wednesday, June 18, 2025

NOTICEOF 2025 ANNUAL MEETINGOF STOCKHOLDERSOF MEDIFAST, INC.

TO BE HELD ON WEDNESDAY, JUNE 18, 2025

April 29, 2025

DEAR FELLOW STOCKHOLDERS OF MEDI FAST, INC.

Noticeish ereby given that the 2025 annual meeting of stockholders (the"Annual Meeting") of Medi fast, Inc.(the "Company"or"Medifast") willbeheld in person on Wedn esday, June 18, 2025, at 4:30 p. m. Eastern Time at The Four Seasons Baltimore, 200 International Drive, Baltimore, Maryland, 21202, for the following purposes, as more fullyd escribedin the accompanying Proxy Statement:

  1. Elect seven nominees to the Board of Directors to serve for a one-year term expiring in 2026;

  2. Ratify the appointment of RSM US LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2025;

  3. Approve, on an advisory basis, the compensation of the Company's named executive officers;

  4. Approve the Amended and Restated 2012 Share Incentive Plan; and

  5. To tran sact such other business asmay properly comeb efore the Annual Meeting orany adjournment or postponement thereof.

Doors to the Annual Meeting will open at 4:00 p.m. Eastern Time. Stockholders of record at the close of business on April 21, 2025 are entitled to notice of, and to vote at, the Annual Meeting. If you plan to attend the Annual Meeting, please note that for security reasons, before being admitted you must present your proof of stock ownership (or if you hold your shares in street name, a signed legal proxy from your bank, broker or other nominee giving you the right to vote your shares) and valid photo identification at the door. All hand-carried items will be subject to inspection, and any bags, briefcases, or packages must be checked at the registration desk prior to entering the meeting room. If you do not have proof of ownership and valid photo identification, you will not be admitted to the Annual Meeting. Please also note that the use of cellphones, recording and photographic equipment and/or computers is strictly prohibited at the Annual Meeting. No recording of the Annual Meeting is permitted, including audio and video recording.

Jason L. Groves, Esq.

Chief Legal Officer & Corp orate Secretary

Whether or notyou plan toattend the Annual Meeting, please vote yours hares as soonasposs ible bytele phone, viathe Inte rnet or bycompleting, dating, signingand returning aproxycard toensure your shares are voted, or, ifyou holdyours haresin street name, byfollowingthe instructions provided by your bank, broker or other nominee. Submitting your proxynow will not preventyou fromv otingyourshares at the Annual Meetingifyou desire to doso, asyour proxy is revocable atyour option.

TABLE OF CONTENTS

Page
PROXY SUMMARYi
PROXY STATEMENT1
2025 Annual Meeting1
General Information About the Annual Meeting and Voting1
PROPOSAL 1: ELECTION OF DIRECTORS6
INFORMATION CONCERNING OUR BOARD OF DIRECTORS11
Director Independence11
Board Leadership Structure11
Lead Independent Director11
Director Orientation and Continuing Education12
THE COMMITTEES OF THE BOARD12
Audit Committee13
Compensation Committee13
Nominating/Corporate Governance Committee14
Executive Committee14
Board and Committee Self-Assessments14
BOARD'S ROLE IN RISK MANAGEMENT AND ESG OVERSIGHT15
CODE OF CONDUCT AND BUSINESS ETHICS AND CORPORATE GOVERNANCE GUIDELINES15
TRANSACTIONS WITH RELATED PERSONS16
DIRECTOR MEETINGS AND ATTENDANCE16
STOCKHOLDER OUTREACH16
EXECUTIVE OFFICERS17
EXECUTIVE COMPENSATION19
Compensation Discussion and Analysis ("CD&A")19
Compensation Committee Interlocks and Insider Participation29
Compensation Committee Report30
ANALYSIS OF RISK INHERENT IN OUR COMPENSATION POLICIES AND PRACTICES31
EXECUTIVE AND DIRECTOR COMPENSATION TABLES32
PROPOSAL 2: RATIFICATION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR 202543
REPORT OF THE AUDIT COMMITTEE44
INFORMATION REGARDING THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM'S FEES, SERVICES, AND INDEPENDENCE45
PROPOSAL 3: ADVISORY VOTE TO APPROVE THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS46
PROPOSAL 4: APPROVAL OF AMENDED AND RESTATED 2012 SHARE INCENTIVE PLAN47
SECURITIES AUTHORIZED FOR ISSUANCE UNDER EQUITY COMPENSATION PLANS - DECEMBER 31, 202452
SECURITY OWNERSHIP OF PRINCIPAL STOCKHOLDERS53
SECURITY OWNERSHIP OF OFFICERS AND DIRECTORS54
DELINQUENT SECTION 16(A) REPORTS55
ADDITIONAL INFORMATION56
Stockholder Proposals and Nominations for Director56
Charitable Contributions58
Communications with the Board or Its Committees58
APPENDIXA-1
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.